Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. [L'application topique de médicaments anti-fibrinolytiques pour la chirurgie cardiaque avec circulation extra-corporelle : analyse méthodique et méta-analyse.] [English, French abstract] （開啟新視窗）

Abrishami A, Chung F, Wong J.

出處‎: Can J Anaesth 2009;56(3):202-12.

檢索‎: PubMed 19247741

DOI碼‎: 10.1007/s12630-008-9038-x

https://www.ncbi.nlm.nih.gov/pubmed/19247741 （開啟新視窗）

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. （開啟新視窗）

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

出處‎: Heart Lung Circ 2012;21(11):706-10.

檢索‎: PubMed 22842057

DOI碼‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057 （開啟新視窗）

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. （開啟新視窗）

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

出處‎: J Cardiothorac Surg 2009;4:25.

檢索‎: PubMed 19538741

DOI碼‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741 （開啟新視窗）

Current status of pharmacologic therapies in patient blood management. （開啟新視窗）

Goodnough LT, Shander A.

出處‎: Anesth Analg 2013;116(1):15-34.

檢索‎: PubMed 23223098

DOI碼‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 （開啟新視窗）

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. （開啟新視窗）

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

出處‎: Anesth Analg 2009;109(1):15-24.

檢索‎: PubMed 19535691

DOI碼‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691 （開啟新視窗）

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. （開啟新視窗）

Howell N, Senanayake E, Freemantle N, Pagano D.

出處‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

檢索‎: PubMed 22889481

DOI碼‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 （開啟新視窗）

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. （開啟新視窗）

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

出處‎: Anesth Analg 2010;110(1):21-9.

檢索‎: PubMed 19910626

DOI碼‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626 （開啟新視窗）

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion. （開啟新視窗）

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

出處‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

檢索‎: PubMed 22514257

DOI碼‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257 （開啟新視窗）

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. （開啟新視窗）

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

出處‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

檢索‎: PubMed 16935098

DOI碼‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098 （開啟新視窗）

Tranexamic acid in patients undergoing coronary-artery surgery. （開啟新視窗）

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

出處‎: N Engl J Med 2017;376(2):136-48.

檢索‎: PubMed 27774838

DOI碼‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 （開啟新視窗）

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. （開啟新視窗）

Nurözler F, Kutlu T, Küçük G.

出處‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

檢索‎: PubMed 18984759

DOI碼‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 （開啟新視窗）

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. （開啟新視窗）

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

出處‎: JAMA Surg 2013;148(6):538-47.

檢索‎: PubMed 23426385

DOI碼‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 （開啟新視窗）

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. （開啟新視窗）

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

出處‎: JAMA. 2022;328(4):336-47.

檢索‎: PubMed 35881121

DOI碼‎:  10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ （開啟新視窗）

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. （開啟新視窗）

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

出處‎: Anesth Analg 2012;115(2):239-43.

檢索‎: PubMed 21737704

DOI碼‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 （開啟新視窗）

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. （開啟新視窗）

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

出處‎: Ann Thorac Surg 2010;89(5):1489-95.

檢索‎: PubMed 20417766

DOI碼‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 （開啟新視窗）

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. （開啟新視窗）

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

出處‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

檢索‎: PubMed 20067988

DOI碼‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 （開啟新視窗）

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? （開啟新視窗）

Ballen J, Raabe M, Muirhead B.

出處‎: Can J Anaesth 2006;53(4):353-6.

檢索‎: PubMed 16575032

DOI碼‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 （開啟新視窗）

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. （開啟新視窗）

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

出處‎: Transfusion 2013;53(4):798-804.

檢索‎: PubMed 22845023

DOI碼‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 （開啟新視窗）

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. （開啟新視窗）

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

出處‎: Ann Thorac Surg 2008;85(3):836-44.

檢索‎: PubMed 18291152

DOI碼‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 （開啟新視窗）

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. （開啟新視窗）

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

出處‎: Can J Cardiol 2011;27(6):869.e7-8.

檢索‎: PubMed 21983113

DOI碼‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 （開啟新視窗）

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. （開啟新視窗）

Flynn BC, Steiner ME, Mazzeffi M

出處‎: Anesthesiology. 2023 1;139(2):197-210.

檢索‎: PubMed 37155359

DOI碼‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ （開啟新視窗）

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. （開啟新視窗）

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

出處‎: Circulation 2009;120(1):21-7.

檢索‎: PubMed 19546387

DOI碼‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 （開啟新視窗）

Intraoperative use of recombinant activated factor VII during complex aortic surgery. （開啟新視窗）

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

出處‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

檢索‎: PubMed 22285329

DOI碼‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 （開啟新視窗）

Off-label use of recombinant human factor VIIa. （開啟新視窗）

Goodnough LT, Levy JH.

出處‎: Ann Thorac Surg 2014;98(2):393-5.

檢索‎: PubMed 25087781

DOI碼‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 （開啟新視窗）

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). （開啟新視窗）

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

出處‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

檢索‎: PubMed 21550261

DOI碼‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 （開啟新視窗）

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. （開啟新視窗）

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

出處‎: Circulation 2008;118(4):331-8.

檢索‎: PubMed 18606914

DOI碼‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 （開啟新視窗）

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. （開啟新視窗）

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

出處‎: J Vasc Surg 2011;53(4):1032-7.

檢索‎: PubMed 21215579

DOI碼‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 （開啟新視窗）

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. （開啟新視窗）

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

出處‎: Transfus Med Hemother 2012;39(2):139-50.

檢索‎: PubMed 22670132

DOI碼‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 （開啟新視窗）

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. （開啟新視窗）

Lehr EJ, Alford TJ, Wang SH.

出處‎: Heart Surg Forum 2010;13(5):E275-9.

檢索‎: PubMed 20961825

DOI碼‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 （開啟新視窗）

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. （開啟新視窗）

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

出處‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

檢索‎: PubMed 18948033

DOI碼‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 （開啟新視窗）

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. （開啟新視窗）

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

出處‎: Drugs R D 2015;15(2):187-94.

檢索‎: PubMed 25862216

DOI碼‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 （開啟新視窗）

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. （開啟新視窗）

Tanaka KA, Li P, McHugh SM, Subramaniam K.

出處‎: A A Case Rep 2015;5(1):3-5.

檢索‎: PubMed 26125690

DOI碼‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 （開啟新視窗）

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). （開啟新視窗）

Tanaka KA, Waly AA, Cooper WA, Levy JH.

出處‎: Anesthesiology 2003;98(6):1513-5.

檢索‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 （開啟新視窗）

Recombinant activated factor VII in cardiac surgery: a systematic review. （開啟新視窗）

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

出處‎: Ann Thorac Surg 2007;83(2):707-14.

檢索‎: PubMed 17258029

DOI碼‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 （開啟新視窗）

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. （開啟新視窗）

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

出處‎: Transfusion 2014;54(5):1348-57.

檢索‎: PubMed 24898456

DOI碼‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 （開啟新視窗）

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. （開啟新視窗）

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

出處‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

檢索‎: PubMed 22623627

DOI碼‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 （開啟新視窗）

Reducing blood transfusion in aortic surgery: a novel approach. （開啟新視窗）

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

出處‎: Ann Thorac Surg 2019;108(5):1369-75.

檢索‎: PubMed 31255616

DOI碼‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 （開啟新視窗）

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. （開啟新視窗）

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

出處‎: Ann Thorac Surg 2009;88(5):1666-8.

檢索‎: PubMed 19853132

DOI碼‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 （開啟新視窗）

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. （開啟新視窗）

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

出處‎: Crit Care 2016;20:5.

檢索‎: PubMed 26738468

DOI碼‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 （開啟新視窗）

Bloodless orthotopic heart transplantation in a Jehovah's Witness. （開啟新視窗）

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

出處‎: A A Case Rep 2015;4(10):140-2.

檢索‎: PubMed 25974419

DOI碼‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 （開啟新視窗）

State of the art - how I manage coagulopathy in cardiac surgery patients. （開啟新視窗）

Davidson S.

出處‎: Br J Haematol 2014;164(6):779-89.

檢索‎: PubMed 24450971

DOI碼‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 （開啟新視窗）

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. （開啟新視窗）

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

出處‎: Anesthesiology 2011;115(6):1179-91.

檢索‎: PubMed 21970887

DOI碼‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 （開啟新視窗）

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. （開啟新視窗）

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

出處‎: JAMA Netw Open 2021;4(4):e213936.

檢索‎: PubMed 33792729

DOI碼‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 （開啟新視窗）

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. （開啟新視窗）

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

出處‎: Thromb Haemost 2009;102(1):137-44.

檢索‎: PubMed 19572078

DOI碼‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 （開啟新視窗）

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. （開啟新視窗）

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

出處‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

檢索‎: PubMed 23410777

DOI碼‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 （開啟新視窗）

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. （開啟新視窗）

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

出處‎: Anesthesiology 2013;118(1):40-50.

檢索‎: PubMed 23249928

DOI碼‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 （開啟新視窗）

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. （開啟新視窗）

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

出處‎: J Am Heart Assoc 2015;4(6):e002066.

檢索‎: PubMed 26037084

DOI碼‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 （開啟新視窗）

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). （開啟新視窗）

Ranucci M, Baryshnikova E.

出處‎: Br J Anaesth 2016;116(5):618-23.

檢索‎: PubMed 26893405

DOI碼‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 （開啟新視窗）

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. （開啟新視窗）

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

出處‎: Can J Anaesth 2012;59(3):299-303.

檢索‎: PubMed 22161243

DOI碼‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 （開啟新視窗）

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. （開啟新視窗）

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

出處‎: Ann Thorac Surg 2019;107(4):1275-83.

檢索‎: PubMed 30458156

DOI碼‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 （開啟新視窗）

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. （開啟新視窗）

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

出處‎: Anesth Analg 2007;104(4):763-5.

檢索‎: PubMed 17377078

DOI碼‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 （開啟新視窗）

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. （開啟新視窗）

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

出處‎: Scand J Clin Lab Invest 2012;72(2):121-8.

檢索‎: PubMed 22233480

DOI碼‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 （開啟新視窗）

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. （開啟新視窗）

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

出處‎: Anaesthesia 2010;65(7):688-91.

檢索‎: PubMed 20477783

DOI碼‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 （開啟新視窗）

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. （開啟新視窗）

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

出處‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

檢索‎: PubMed 18068065

DOI碼‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 （開啟新視窗）

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. （開啟新視窗）

Wademan BH, Galvin SD.

出處‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

檢索‎: PubMed 24263581

DOI碼‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 （開啟新視窗）

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. （開啟新視窗）

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

出處‎: Anesth Analg 2010;110(3):702-7.

檢索‎: PubMed 20042444

DOI碼‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 （開啟新視窗）

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. （開啟新視窗）

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

出處‎: Ann Surg 2010;251(2):217-28.

檢索‎: PubMed 20010084

DOI碼‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 （開啟新視窗）

A review of topical hemostatic agents for use in cardiac surgery. （開啟新視窗）

Barnard J, Millner R.

出處‎: Ann Thorac Surg 2009;88(4):1377-83.

檢索‎: PubMed 19766855

DOI碼‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 （開啟新視窗）

Armentarium of topical hemostatic products in cardiovascular surgery: an update. （開啟新視窗）

Forcillo J, Perrault LP.

出處‎: Transfus Apher Sci 2014;50(1):26-31.

檢索‎: PubMed 24412443

DOI碼‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 （開啟新視窗）

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. （開啟新視窗）

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

出處‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

檢索‎: PubMed 23134676

DOI碼‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 （開啟新視窗）

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. （開啟新視窗）

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

出處‎: Innovations (Phila) 2012;7(4):229-41.

檢索‎: PubMed 23123988

DOI碼‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 （開啟新視窗）

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). （開啟新視窗）

Salerno TA, Gaughan C, Suarez M, Panos AL.

出處‎: J Card Surg 2009;24(6):722-4.

檢索‎: PubMed 20078720

DOI碼‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 （開啟新視窗）

Topical haemostatic agents. （開啟新視窗）

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

出處‎: Br J Surg 2008;95(10):1197-225.

檢索‎: PubMed 18763249

DOI碼‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 （開啟新視窗）

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. （開啟新視窗）

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

出處‎: Transfus Med 2006;16(1):31-9.

檢索‎: PubMed 16480437

DOI碼‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 （開啟新視窗）

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. （開啟新視窗）

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

出處‎: Anesthesiology 2011;115(6):1179-91.

檢索‎: PubMed 21970887

DOI碼‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 （開啟新視窗）

Management of hemorrhage in cardiothoracic surgery. （開啟新視窗）

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

出處‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

檢索‎: PubMed 23910533

DOI碼‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 （開啟新視窗）

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. （開啟新視窗）

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

出處‎: Anesthesiology 2012;117(3):531-47.

檢索‎: PubMed 22914710

DOI碼‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 （開啟新視窗）